Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers

Ítems similars

• Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain
  per: Yu, Helena A., et al.
  Publicat: (2015)
• Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited Tumor Samples
  per: Borsu, Laetitia, et al.
  Publicat: (2016)
• Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
  per: Yu, H. A., et al.
  Publicat: (2014)
• Germline EGFR T790M mutation found in multiple members of a familial cohort
  per: Yu, Helena A., et al.
  Publicat: (2014)
• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  per: Oxnard, Geoffrey R., et al.
  Publicat: (2010)